We are live on
!
Find out more
HCM
Hoplite Capital Management Portfolio holdings
AUM
$15.1M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
-27.41%
3 Year Est. Return
+32.9%
5 Year Est. Return
+85.27%
10 Year Est. Return
–
AUM
$3.56B
AUM Growth
+$742M
(+26%)
Cap. Flow
+$451M
Cap. Flow
% of AUM
12.68%
Top 10 Holdings %
Top 10 Hldgs %
44.63%
Holding
43
New
12
Increased
9
Reduced
11
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$112M |
| 2 |
AGN
Allergan plc
AGN
|
+$91.2M |
| 3 |
Adobe
ADBE
|
+$89.6M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$80.9M |
| 5 |
Herbalife
HLF
|
+$69.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cemex
CX
|
+$138M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$103M |
| 3 |
Carter's
CRI
|
+$64.9M |
| 4 |
Universal Health Services
UHS
|
+$61.6M |
| 5 |
Estee Lauder
EL
|
+$50.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.29% |
| 2 | Healthcare | 23.23% |
| 3 | Consumer Staples | 18.25% |
| 4 | Technology | 8.9% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
26
DELISTED
Endo International plc
ENDP
| $68.5M | 1.93% |
+1,015,958
| New | +$58M |
|
27
Capri Holdings
CPRI
$1.88B
| $64.6M | 1.82% |
795,427
-371,280
| -32% | -$29.3M |
|
28
Baidu
BIDU
$38.2B
| $64.1M | 1.8% |
+360,609
| New | +$58.3M |
|
29
Designer Brands
DBI
$331M
| $64M | 1.8% |
+1,497,960
| New | +$65M |
|
30
Fortinet
FTNT
$123B
| $61.3M | 1.72% |
16,018,445
| – | – |
|
|
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
| $58.4M | 1.64% |
+1,017,481
| New | +$59.2M |
|
|
SCTY
32
DELISTED
SolarCity Corporation
SCTY
| $52.6M | 1.48% |
+925,257
| New | +$47.6M |
|
|
HOUS
33
DELISTED
Anywhere Real Estate
HOUS
| $50M | 1.41% |
1,010,652
| – | – |
|
34
Danaher
DHR
$139B
| $47.8M | 1.35% |
922,137
| – | – |
|
|
INXN
35
DELISTED
Interxion Holding N.V.
INXN
| $46.8M | 1.32% |
1,981,342
| – | – |
|
|
ARG
36
DELISTED
Airgas Inc
ARG
| $46.3M | 1.3% |
413,545
-8,475
| -2% | -$923K |
|
37
CALL
Louisiana-Pacific
LPX
$5.15B
| $9.26M | 0.26% |
500,000
| – | – |
|
38
Crown Holdings
CCK
$13B
| $1.57M | 0.04% |
+35,345
| New | +$1.51M |
|
39
Berkshire Hathaway Class A
BRK.A
$1.1T
| $356K | 0.01% |
2
| – | – |
|
|
40
Cemex
CX
$17.1B
| – | – |
-14,427,592
| Closed | -$138M |
|
41
CALL
H&R Block
HRB
$5.73B
| – | – |
-2,000,000
| Closed | -$53.3M |
|
|
42
Universal Health Services
UHS
$10.2B
| – | – |
-821,939
| Closed | -$61.6M |
|
|
TWX
43
DELISTED
Time Warner Inc
TWX
| – | – |
-1,630,237
| Closed | -$103M |
|
Similar funds
PCP
DCM
FCM
RGNCM
ICP
PVAM
CIM
LAM
Hoplite Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Hoplite Capital Management held 43 positions worth $3.56B, up 26% from $2.81B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Hoplite Capital Management deployed $451M of net new capital in Q4 2013, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,084,304 shares worth $137M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Carter's, an estimated $64.9M trimmed.
- Hoplite Capital Management's largest Q4 2013 buy was Jazz Pharmaceuticals: 1,084,304 shares worth $137M.
- Hoplite Capital Management added most to Allergan plc in Q4 2013, an estimated $91.2M increase.
- Hoplite Capital Management's biggest Q4 2013 reduction was Carter's, cutting an estimated $64.9M.
- Hoplite Capital Management fully exited Cemex in Q4 2013, selling an estimated $138M.
- Hoplite Capital Management's ten largest holdings make up 45% of its $3.56B portfolio in Q4 2013.
- Hoplite Capital Management opened 12 new positions and closed 4 in Q4 2013.
- Hoplite Capital Management's portfolio value rose 26% quarter-over-quarter to $3.56B.
Based on Hoplite Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.